Pfizer Inc.Profile
|
|
Share Price & Volume
| Previous Close | $26.61 | |
| Open | -0.26% | $26.54 |
| Day Low | -1.43% | $26.23 |
| Day High | +1.95% | $27.13 |
| 52-Week Low | -21.38% | $20.92 |
| 52-Week High | +5.00% | $27.94 |
| Day Volume | 45,403,115 | |
| Average Volume | 47,369,333 | |
| EPS (TTM) | $1.38 | |
| P/E (TTM) | 19.60x | |
| FWD P/E (NTM) | 8.98x | |
| Next Earnings Date | Apr 28, 2026 |
| Market Cap | 153,813,532,656 | |
| Shares Outstanding (Millions) | 5,686,267,381 | |
| Dividend | $1.72 (6.46%) | |
| Beta | 0.41 | |
| ROE | 0.09% | |
| ROA | 0.06% |
Analyst Ratings and Price Targets
Current:
$27.05
Average:
$27.44
(+1.46%)
Low:
$25.00
(-7.58%)
High:
$35.00
(+29.39%)
| Argus Research | Upgrades | Buy | $35.00 | +29.39% | Mar 1, 2026 |
| RBC Capital | Initiates Coverage On | Underperform | $25.00 | -7.58% | Feb 25, 2026 |
| Barclays | Initiates Coverage On | Underweight | $25.00 | -7.58% | Feb 20, 2026 |
| Cantor Fitzgerald | Reiterates | Neutral | $27.00 | -0.18% | Feb 4, 2026 |
| Cantor Fitzgerald | Maintains | Neutral | $27.00 | -0.18% | Jan 27, 2026 |
| UBS | Assumes | Neutral | $25.00 | -7.58% | Jan 7, 2026 |
| Morgan Stanley | Maintains | Equal-Weight | $27.00 | -0.18% | Dec 17, 2025 |
| B of A Securities | Maintains | Neutral | $28.00 | +3.51% | Dec 15, 2025 |
| Morgan Stanley | Maintains | Equal-Weight | $28.00 | +3.51% | Dec 12, 2025 |
Headquarters
New York City, NY, USA
Sector
# of Employees
81,000